ID27904A - Metode untuk menyiapkan inhibitor penukar natrium-hidrogen tipe 1 - Google Patents

Metode untuk menyiapkan inhibitor penukar natrium-hidrogen tipe 1

Info

Publication number
ID27904A
ID27904A IDP20000929A ID20000929A ID27904A ID 27904 A ID27904 A ID 27904A ID P20000929 A IDP20000929 A ID P20000929A ID 20000929 A ID20000929 A ID 20000929A ID 27904 A ID27904 A ID 27904A
Authority
ID
Indonesia
Prior art keywords
nathum
preparing
exchange type
hydrogen exchange
type inhibitors
Prior art date
Application number
IDP20000929A
Other languages
English (en)
Indonesian (id)
Inventor
Norma Jacqueline Tom
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID27904A publication Critical patent/ID27904A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/10—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP20000929A 1999-10-29 2000-10-27 Metode untuk menyiapkan inhibitor penukar natrium-hidrogen tipe 1 ID27904A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16237799P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
ID27904A true ID27904A (id) 2001-05-03

Family

ID=22585372

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP20000929A ID27904A (id) 1999-10-29 2000-10-27 Metode untuk menyiapkan inhibitor penukar natrium-hidrogen tipe 1

Country Status (19)

Country Link
US (1) US6441176B1 (enExample)
EP (1) EP1101763A3 (enExample)
JP (1) JP3342475B2 (enExample)
KR (2) KR100449595B1 (enExample)
CN (1) CN1146557C (enExample)
AR (1) AR029188A1 (enExample)
AU (1) AU779106B2 (enExample)
BR (1) BR0005122A (enExample)
CA (1) CA2324640A1 (enExample)
CZ (1) CZ20004018A3 (enExample)
HU (1) HUP0004187A2 (enExample)
ID (1) ID27904A (enExample)
IL (1) IL139198A0 (enExample)
PL (1) PL343542A1 (enExample)
RU (1) RU2190605C2 (enExample)
TR (1) TR200003143A2 (enExample)
TW (1) TWI221152B (enExample)
YU (1) YU62900A (enExample)
ZA (1) ZA200006007B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852733B2 (en) 2000-04-28 2005-02-08 Pfizer Inc. Sodium-hydrogen exchanger type 1 inhibitor
CA2436539A1 (en) * 2001-01-31 2002-08-08 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
MXPA04004685A (es) * 2001-12-19 2004-08-12 Pfizer Prod Inc Procedimientos para preparar inhibidores de tipo-1 de intercambiador sodio-hidrogeno.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028381A (en) * 1975-05-05 1977-06-07 Ciba-Geigy Corporation Pyrazolobenzazepines
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
RU2009129C1 (ru) * 1991-12-16 1994-03-15 Центр по химии лекарственных средств Арилгидразоны 5,6,7,8-тетрагидрохинолиндионы-2,5, обладающие кардиотонической активностью
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
JP2002504546A (ja) 1998-02-27 2002-02-12 ファイザー・プロダクツ・インク 虚血の治療のためのｎ−［（置換５員ジもしくはトリアザ二不飽和環）カルボニル］グアニジン誘導体
UA72002C2 (en) 1999-10-29 2005-01-17 Pfizer Prod Inc Inhibitors crystals of sodium-hydrogen exchange of 1 type, a method for the preparation thereof (variants), a pharmaceuticalcomposition based thereon and a method for the reduction of tissue damage

Also Published As

Publication number Publication date
YU62900A (sh) 2003-08-29
KR100449595B1 (ko) 2004-09-21
CA2324640A1 (en) 2001-04-29
AR029188A1 (es) 2003-06-18
TR200003143A2 (tr) 2001-05-21
JP3342475B2 (ja) 2002-11-11
CN1146557C (zh) 2004-04-21
US6441176B1 (en) 2002-08-27
PL343542A1 (en) 2001-05-07
KR20010060211A (ko) 2001-07-06
IL139198A0 (en) 2001-11-25
RU2190605C2 (ru) 2002-10-10
CZ20004018A3 (cs) 2002-04-17
TWI221152B (en) 2004-09-21
JP2001158784A (ja) 2001-06-12
BR0005122A (pt) 2001-06-19
HK1036057A1 (en) 2003-07-10
CN1295070A (zh) 2001-05-16
ZA200006007B (en) 2002-04-26
EP1101763A3 (en) 2002-04-24
EP1101763A2 (en) 2001-05-23
HUP0004187A2 (hu) 2002-11-28
AU6133300A (en) 2001-05-03
AU779106B2 (en) 2005-01-06
KR20030061767A (ko) 2003-07-22
KR100443851B1 (ko) 2004-08-11
HU0004187D0 (enExample) 2001-01-29

Similar Documents

Publication Publication Date Title
ATE245142T1 (de) No-synthase inhibitoren
FI990323A7 (fi) Menetelmä tiedon turvaamiseksi
ID18142A (id) Inhibitor metaloprotease 1,4-heterosiklik
ATE512949T1 (de) Reninhemmer
NO20015900L (no) Metalloprotease-inhibitorer
DE60013420D1 (de) Verfahren zum ringförmigen abdichten
ATE236167T1 (de) P38 inhibitoren
ID24509A (id) Metode penyediaan pendinginan
FI971104L (fi) Menetelmä COX-inhibiittoreina käyttökelpoisten fenyyliheterosyklien valmistamiseksi
ID23983A (id) Inhibitor-inhibitor aminotiazol untuk kinase-kinase tergantung siklin
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
ID27574A (id) Inhibitor enzim
NO20011293D0 (no) Faktor VIIa-inhibitorer
NO20016319L (no) VLA-4 inhibitor-forbindelser
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
EP1185528A4 (en) INHIBITORS OF IL-12 PRODUCTION
DE60035039D1 (de) Renin inhibitoren
PT1171440E (pt) 3-ciano-¬1,7|,¬1,5|, e ¬1,8|-naftiridinas substituidas inibidoras de tirosina quinases
NO20005826L (no) Bionedbrytbare korrosjonsinhibitorer
DE59806475D1 (de) Urokinase-inhibitoren
ID27270A (id) Aparatus pemroses informasi program siaran
DE69913206D1 (de) Verfahren für thermischen massenübertragungsdruck
ATE252547T1 (de) Matrixmetalloproteinaseinhibitoren
FI20000553L (fi) Proteaasi-inhibiittoreina käyttökelpoisten 4-hydroksi-2-oksopyraanijohdannaisten valmistusmenetelmä
DE60024951D1 (de) Verfahren zum biegen von rohren